How to develop and implement a national drug policy [[electronic resource]]

• Record Nr.: UNINA9910780304003321
• Pubbl/distr/stampa: Geneva, : World Health Organization, c2001
• ISBN: 92-4-068069-1
• Edizione: [2nd ed.]
• Descrizione fisica: 1 online resource (96 p.)
• Disciplina: 362.1/782
• Soggetti: Pharmaceutical policy; Drug utilization
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Updates and replaces Guidelines for developing national drug policies, 1988.
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: Contents; Contributors; Abbreviations and acronyms; Preface; 1. Introduction; 2. The national drug policy process; 3. Legislation; 4. Selection of essential drugs; 5. Affordability; 6. Drug financing; 7. Supply systems; 8. Drug regulation; 9. Rational use of drugs; 10. Research; 11. Human resources development; 12. Monitoring and evaluation; References
• Sommario/riassunto: In Europe today, HIV/AIDS prevention, treatment and care are needed more than ever. HIV incidence steady in western and central Europe, and dramatically increasing in eastern Europe remains a major challenge to public health in the 21st century. With more than two million people living with HIV/AIDS in the WHO European Region, no country has been spared. This book tells the story of HIV/AIDS in Europe from a broad variety of perspectives: biomedical, social, cultural, economic and political. The authors are leading experts from across the Region and include both the infected and the affected,